RxDoctor Payments Data

Timothy Kessler, PA

Physician Assistant · Grand Blanc, MINPI 1326215997

Payments from drug & device makers

$4,867in general payments, 2019–2025

Across 344 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$1K
  • AbbVie$987
  • Pfizer$239
  • Regeneron Healthcare Solutions, Inc.$201
  • Boehringer Ingelheim$160
  • plus $742 from 17 others

What the payments were for

  • Food & beverage$4,28588%
  • Education$58212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,867 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$120,306
Medicare patients
579
Services billed
2,633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa50$999,916
Cosentyx Unoready PenSecukinumab60$512,079
TremfyaGuselkumab21$272,075
Cosentyx Sensoready (2 Pens)Secukinumab29$214,110
Dupixent PenDupilumab49$187,840
Humira PenAdalimumab12$85,564
XolairOmalizumab14$34,860
Fluorouracil173$10,220
Tretinoin167$7,292
Clobetasol Propionate217$6,650
Betamethasone Valerate191$5,614
Acitretin13$4,225
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc201$4,031
Triamcinolone Acetonide203$3,630
Ketoconazole229$3,411

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$1,146$272,07521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →